---
document_datetime: 2023-09-21 21:20:09
document_pages: 29
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ferriprox-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: ferriprox-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 18.9538528
conversion_datetime: 2025-12-30 09:35:21.091738
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Ferriprox

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                         |
|----------------------|------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0158              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation | 30/09/2022                          |                                             | SmPC, Labelling and PL           | To update the SmPC section 4.6 following the recommendations from SWP regarding the contraception and genotoxicity. The Package Leaflet and patient alert card have been updated accordingly - also in the RMP. |
| IA/0156              | B.II.b.5.z - Change to in-process tests or limits                                              | 16/05/2022                          | n/a                                         |                                  |                                                                                                                                                                                                                 |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                   | applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                                                      |            |            |                                  |                                   |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| IA/0155           | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                          | 13/04/2022 | n/a        |                                  |                                   |
| PSUSA/940/2 02108 | Periodic Safety Update EU Single assessment - deferiprone                                                                                                                                                                                                                                                                                                     | 07/04/2022 | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0153           | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                | 11/01/2022 |            | SmPC, Annex II, Labelling and PL |                                   |
| IA/0152           | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                 | 08/01/2021 | 06/01/2022 | Annex II and PL                  |                                   |
| IB/0151           | B.II.e.1.a.2 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Semi-solid and non-sterile liquid pharmaceutical forms                                                                                                                                                                                      | 08/01/2021 | n/a        |                                  |                                   |
| IA/0150/G         | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.1.c - Change in the specification parameters and/or limits of the finished product - Addition of a new specification parameter to the specification with its corresponding test method | 09/12/2020 | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

| IA/0149   | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                                                                  | 26/11/2020   | n/a        |                        |           |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------|
| N/0148    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                | 19/11/2020   | 06/01/2022 | PL                     |           |
| IA/0147   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                                                                                    | 16/06/2020   | n/a        |                        |           |
| T/0146    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                             | 07/04/2020   | 04/05/2020 | SmPC, Labelling and PL |           |
|           | This was an application for a group of variations. B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method | 13/03/2020   | n/a        |                        | IA/0144/G |
| IA/0143/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                              | 06/03/2020   | n/a        |                        |           |

<div style=\"page-break-after: always\"></div>

|           | in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information   |            |            |                                  | B.II.e.2.c - Change   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------|
| IAIN/0142 | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                         | 16/12/2019 | 04/05/2020 | SmPC, Annex II, Labelling and PL |                       |
| IAIN/0141 | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                                                                                                                                                                                                | 16/10/2019 | n/a        |                                  |                       |
| IA/0140/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                       | 03/09/2019 | n/a        |                                  |                       |
| IA/0138/G | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of                                                                                                                                                                                                                       | 03/09/2019 | n/a        |                                  |                       |

<div style=\"page-break-after: always\"></div>

|           | limits - Change in test procedure for the finished - Minor changes to an approved test                                                                                                                                                                                                                                                                                                                                              |            |     | specification B.II.d.2.a product procedure   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------------------|
| IA/0139   | B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                               | 30/08/2019 | n/a |                                              |
|           | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                 | 13/08/2019 | n/a | IAIN/0137/G                                  |
| IA/0136/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation | 18/07/2019 | n/a |                                              |
| IA/0135/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                  | 11/07/2019 | n/a |                                              |

<div style=\"page-break-after: always\"></div>

|         | B.II.a.3.b.1 - Changes in the composition (excipients) of the finished product - Other excipients - Any minor adjustment of the quantitative composition of the finished product with respect to excipients B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                    |            |            |                                  |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| II/0128 | Update section 4.4 of the SmPC and the patient/carer reminder card in order to change the recommended frequency of absolute neutrophil count (ANC) monitoring throughout Ferriprox treatment to weekly during the first year of therapy and to every 2 or 4 weeks after one year of therapy. Section 4.8 of the SmPC and the package leaflet have been updated accordingly. The RMP version 13.2 has been agreed. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data | 11/07/2019 | 04/05/2020 | SmPC, Annex II, Labelling and PL |
| IA/0134 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 18/06/2019 | n/a        |                                  |
| IA/0133 | B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete                                                                                                                                                                                                                                                                                                                          | 13/06/2019 | n/a        |                                  |

<div style=\"page-break-after: always\"></div>

|                   | parameter)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |            |            |                        |                                   |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IAIN/0132         | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 27/05/2019 | 04/05/2020 | Annex II and PL        |                                   |
| T/0131            | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 17/04/2019 | 13/05/2019 | SmPC, Labelling and PL |                                   |
| PSUSA/940/2 01808 | Periodic Safety Update EU Single assessment - deferiprone                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 14/03/2019 | n/a        |                        | PRAC Recommendation - maintenance |
| II/0126/G         | This was an application for a group of variations. Update of sections 4.2, 4.4 and 5.2 of the SmPC in order to update safety information on the use of Ferriprox in patients with renal or hepatic impairment, based on the final results of two clinical studies LA39-0412 (An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox in Subjects with Impaired Renal Function and Healthy Volunteers) and LA40-0412 (An Open-Label Study to Compare the Pharmacokinetic Profiles of a Single Dose of Ferriprox in Subjects with Impaired Hepatic Function and Healthy Volunteers). The studies are listed as category 3 study in the RMP. The Package leaflet and labelling are updated accordingly. In addition, the Marketing authorisation holder (MAH) took the opportunity to make some | 31/01/2019 | 11/03/2019 | SmPC and PL            |                                   |

<div style=\"page-break-after: always\"></div>

|             | in the PI. The RMP version 13.1 has also been submitted to include consequential changes regarding these two clinical studies, to introduce minor changes requested to be addressed at the next regulatory procedure and to update the RMP format in line with the GVP Module V Rev 2 template. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance   |            |     | minor edits data   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|
| IA/0129     | B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                                                                                                                                                                                                                                                            | 25/10/2018 | n/a |                    |
| IA/0127/G   | This was an application for a group of variations. B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                     | 10/10/2018 | n/a |                    |
| IAIN/0125/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 27/07/2018 | n/a |                    |

<div style=\"page-break-after: always\"></div>

|                   | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.III.2.a.1 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS   |            |     |                                   |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IA/0124           | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                  | 28/06/2018 | n/a |                                   |
| IA/0123           | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                                                                                                                                                | 27/04/2018 | n/a |                                   |
| PSUSA/940/2 01708 | Periodic Safety Update EU Single assessment - deferiprone                                                                                                                                                                                                                                                                                                                                            | 12/04/2018 | n/a | PRAC Recommendation - maintenance |
| IB/0120           | B.II.f.1.e - Stability of FP - Change to an approved stability protocol                                                                                                                                                                                                                                                                                                                              | 12/12/2017 | n/a |                                   |
| IA/0122           | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the                                                                                                                                                                                                                                                                                                            | 08/12/2017 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|                   | dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                                                                                     |            |            |                                  |                                                                                                                        |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------|
| IA/0119           | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                         | 30/11/2017 | n/a        |                                  |                                                                                                                        |
| IB/0118/G         | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation | 13/11/2017 | n/a        |                                  |                                                                                                                        |
| IA/0117           | B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits                                                                                                                                                                                                                                                            | 20/07/2017 | n/a        |                                  |                                                                                                                        |
| IB/0116/G         | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                              | 04/07/2017 | 12/04/2018 | SmPC, Annex II, Labelling and PL |                                                                                                                        |
| PSUSA/940/2 01608 | Periodic Safety Update EU Single assessment - deferiprone                                                                                                                                                                                                                                                                                                                                                            | 23/03/2017 | 24/05/2017 | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                              |            |            |                        | PSUSA/940/201608.   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------|
| IA/0115   | B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s)                                                                                                                                                        | 18/05/2017 | 12/04/2018 | SmPC, Labelling and PL |                     |
| IB/0112   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                 | 31/01/2017 | n/a        |                        |                     |
| IAIN/0114 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                           | 17/01/2017 | n/a        |                        |                     |
| IA/0113   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 12/01/2017 | n/a        |                        |                     |
| IA/0110   | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                 | 01/09/2016 | n/a        |                        |                     |
| IB/0109   | B.II.e.1.a.2 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Semi-solid and non-sterile liquid pharmaceutical forms                                                                     | 01/09/2016 | n/a        |                        |                     |
| IA/0108   | B.II.b.4.a - Change in the batch size (including batch                                                                                                                                                                                       | 24/06/2016 | n/a        |                        |                     |

<div style=\"page-break-after: always\"></div>

|                   | size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|-------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0103           | C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one                                                                                                                                                                                                                                                                                                                                                                                | 28/04/2016 | 26/05/2016 | SmPC, Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| PSUSA/940/2 01508 | Periodic Safety Update EU Single assessment - deferiprone                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 17/03/2016 | n/a        |                       | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IA/0107           | B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products                                                                                                                                                                                                                                                                                                                                                                                | 22/12/2015 | n/a        |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IA/0105           | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                                                                                                                                                           | 22/10/2015 | n/a        |                       |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| II/0089/G         | This was an application for a group of variations. Update of section 5.1 of the SmPC with the results of Study LA37-1111; a double-blind randomized, crossover, thorough QT/QTc trial to evaluate the potential of deferiprone to prolong the QT interval in healthy subjects. Further, the MAH took the opportunity to update the SmPC, Annex II and Package Leaflet in line with the QRD template version 9, and to update the contact details of the Croatian local representative in the Package Leaflet. | 22/10/2015 | 26/05/2016 | SmPC, Annex II and PL | Study LA37-1111 was conducted to evaluate the effect of single therapeutic (33 mg/kg) and supratherapeutic (50 mg/kg) oral doses of deferiprone on the cardiac QT interval duration in healthy subjects. The maximum difference between the LS means of the therapeutic dose and placebo was 3.01 msec (95% one-sided UCL: 5.01 msec), and between the LS means of the supratherapeutic dose and placebo was 5.23 msec (95% one-sided UCL: 7.19 msec). Ferriprox was concluded to produce no significant prolongation of the QT interval. |

<div style=\"page-break-after: always\"></div>

|           | The updated RMP version 8.1 was agreed as part of this procedure. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                  |            |     |           |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| IA/0104   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                       | 24/09/2015 | n/a |           |
| IA/0102   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                    | 04/09/2015 | n/a |           |
|           | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure | 12/08/2015 | n/a | IA/0101/G |
| IAIN/0100 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                     | 22/07/2015 | n/a |           |

<div style=\"page-break-after: always\"></div>

| IB/0099           | B.II.e.1.a.2 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Semi-solid and non-sterile liquid pharmaceutical forms                                                                                                                                                                                                                 | 23/04/2015   | n/a   |                                   |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| IA/0098           | B.II.e.2.b - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                                                                                 | 23/04/2015   | n/a   |                                   |
| IA/0097           | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                                                                                                                                    | 26/03/2015   | n/a   |                                   |
| PSUSA/940/2 01408 | Periodic Safety Update EU Single assessment - deferiprone                                                                                                                                                                                                                                                                                                                                | 12/03/2015   | n/a   | PRAC Recommendation - maintenance |
| IAIN/0096/G       | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV and/or QPPV contact details and/or back-up procedure C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the PhV system | 05/02/2015   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

| IA/0095   | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State                                                                                                                                                                                                                                                              | 19/12/2014   | n/a   |             |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------|
| IA/0094   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                      | 04/12/2014   | n/a   |             |
| IA/0092   | B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method                                                                                                                                                                                                                                                                                              | 01/12/2014   | n/a   |             |
|           | This was an application for a group of variations. C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) in the safety database and/or major contractual arrangements for the fulfilment of PhV obligations, and/or change of the site undergoing PhV activities C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the PhV system | 08/08/2014   | n/a   | IAIN/0091/G |
| IA/0090   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                | 30/07/2014   | n/a   |             |
| IA/0088   | B.II.b.2.a - Change to importer, batch release                                                                                                                                                                                                                                                                                                                                                                                                                                     | 25/04/2014   | n/a   |             |

<div style=\"page-break-after: always\"></div>

|           | arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUV/0087 | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 10/04/2014 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                               |
| II/0084   | Update of section 4.8 of the SmPC in order to add hypersensitivity reactions, rash and urticaria as ADRs in the course of Ferriprox treatment in conclusion to the assessment of the 22nd PSUR. The Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to make a minor editorial change to section 5.2 of the SmPC and to update the list of local representatives in the Package Leaflet. Furthermore, the PI is being brought in line with version 8.3 (January 2013) of the QRD template. C.I.3.b - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR, RMP, FUM/SO, data submitted under Article 45/46, or amendments to reflect a Core SPC - Change(s) with new additional data submitted by the | 25/04/2013 | 23/04/2014 | SmPC, Annex II, Labelling and PL | As a follow-up to the assessment of the 22nd yearly PSUR, covering the period from 1 September 2010 to 31 August 2011, hypersensitivity reactions, rash and urticaria were included in the list of ADRs observed in the course of Ferriprox treatment following relevant cases from spontaneous reporting which were accompanied with positive dechallenge and rechallenge suggesting a causal relationship between these events and Ferriprox. |
| IAIN/0086 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 22/04/2013 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| IAIN/0085 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 20/03/2013 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| IAIN/0083   | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                                                                                                                                                                                                                                                                                                                                                                                                                                           | 05/12/2012   | n/a   |                |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|----------------|
| IA/0082/G   | This was an application for a group of variations. B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material B.III.2.a.2 - Change of specification(s) of a former non Pharmacopoeial substance to comply with the Ph. Eur. or with a national pharmacopoeia of a Excipient/AS starting material | 25/10/2012   | n/a   | Member State - |
| IA/0080/G   | This was an application for a group of variations. B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                              | 12/09/2012   | n/a   |                |

<div style=\"page-break-after: always\"></div>

| IB/0079   | - Stability of FP - Extension of the shelf of the finished product - As packaged for sale by real time data)                                                                                                                                                                                                                                           | 01/08/2012   | 25/10/2012   | SmPC   | B.II.f.1.b.1 life (supported      |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------|-----------------------------------|
|           | This was an application for a group of variations. B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect | 24/05/2012   | n/a          |        | IA/0078/G the product information |
| N/0076    | Update of name and contact information of local representatives for Bulgaria, Hungary, Poland, Romania, Slovenia and Slovakia for the package leaflet. Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                | 30/03/2012   | 25/10/2012   | PL     |                                   |
| IB/0077   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                              | 21/03/2012   | 25/10/2012   | SmPC   |                                   |
| IA/0075/G | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                                                                                                                                                                  | 02/12/2011   | n/a          |        |                                   |

<div style=\"page-break-after: always\"></div>

|         | procedure B.II.b.4.b - Change in the batch size (including batch size ranges) of the finished product - Downscaling down to 10-fold                                                                                                                                                                                                                                                                            |            |     |                 |                            |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------|----------------------------|
| IA/0074 | B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the currently approved batch                                                                                                                                                                                                                                                         | 30/08/2011 | n/a |                 | size                       |
| N/0070  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                               | 24/08/2011 | n/a | Annex II and PL |                            |
|         | This was an application for a group of variations. B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data B.I.c.2.d - Change in the specification parameters and/or limits of the immediate packaging of the AS - Addition or replacement of a specification parameter safety or quality issue | 22/08/2011 | n/a |                 | IB/0073/G as a result of a |
| IA/0072 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                             | 18/07/2011 | n/a |                 |                            |
| IA/0071 | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect                                                                                                                                                                                                                                                         | 27/06/2011 | n/a |                 |                            |

<div style=\"page-break-after: always\"></div>

|           | the product information                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     |                                   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IB/0069/G | for a group of variations. B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                                                                                                                                                                                                                                                                                                                                                                         | 18/04/2011 | n/a | This was an application procedure |
| IA/0067   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 06/01/2011 | n/a | site                              |
| IA/0065/G | This was an application for a group of variations. B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits | 03/12/2010 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

| IA/0066   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                                                                            | 29/11/2010   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0064    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                      | 30/09/2010   | n/a        | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| II/0063   | Update of sections 4.6 and 5.3 of the Summary of Product Characteristics (SmPC) with new information from non-clinical studies. Minor editorial amendments were also introduced in the SmPC, Labelling and Package Leaflet (PL). C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data                                                                                                               | 24/06/2010   | 06/08/2010 | SmPC, Labelling and PL           | No effects of deferiprone on fertility and early embryonic development were noted in animals. A delay in time to confirmed mating was noted in female rats, which was attributed to a prolongation of the oestrous cycle.                                                                                                                                                                                                                                                                                                                                                          |
| X/0058    | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                                                                                                                                                                                                                                                                                                                                                            | 20/05/2010   | 28/07/2010 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| II/0062   | C.I.4 - Variations related to significant modifications of the Summary of Product Characteristics due in particular to new quality, pre-clinical, clinical or pharmacovigilance data Update of section 5.1 of the Summary of Product Characteristics (SmPC) with new information from two clinical studies investigating the potential cardioprotective effect of deferiprone-mediated iron chelation. Changes to improve readability and clarity were introduced in sections 4.2, 4.4 and 4.8 of the | 20/05/2010   | 05/07/2010 | SmPC, Annex II, Labelling and PL | Following review of a newly submitted prospective clinical study with the objective to examine the effect of deferiprone on protecting myocardial tissue from iron deposition (study LA 16-0102) and a previously reviewed retrospective study with similar objectives (LA 12-9907), section 5.1 of the SmPC was revised significantly. The studies described in 5.1 show that Ferriprox is effective in removing transfusional iron overload and in protecting myocardial tissue from iron deposition and consequent loss of cardiac function. Moreover, the warning and posology |

<div style=\"page-break-after: always\"></div>

|           | SmPC and in the Labelling. Annex II has been updated to reflect the switch to the annual PSUR cycle. Editorial changes were made to the SmPC. The Product Information has been updated in accordance with the latest QRD template (version 7.3.1, March 2010). C.I.4 - Variations related to significant modifications of the SPC due in particular to new quality, pre- clinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                   |            |            | recommendation on agranulocytosis was moved from section 4.4 to section 4.2 of the SmPC and the wording on the posology recommendation was expanded. The structure of section 4.8 of the SmPC was revised based on the recommendation of the SmPC Guideline (Revision 2, September 2009).   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0061/G | This was an application for a group of variations. To introduce changes in the in-process testing and minor changes in the manufacturing process of the finished product. B.II.b.3.a - Change in the manufacturing process of the finished product - Minor change in the manufacturing process of an immediate release solid oral dosage form or oral solutions B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.b.5.e - Change to in-process tests or limits applied during the manufacture of the finished product - Widening of the approved IPC limits, which may have a significant effect on overall quality of the finished product | 22/04/2010 | 04/05/2010 |                                                                                                                                                                                                                                                                                             |
| IB/0060   | B.II.e.1.a.2 - Change in immediate packaging of the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 26/02/2010 | n/a        |                                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|         | finished product - Qualitative and quantitative composition - Semi-solid and non-sterile liquid pharmaceutical forms                                              |            |            |                                  |                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0068 | B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products                                    | 05/01/2010 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                    |
| IA/0059 | IA_28_Change in any part of primary packaging material not in contact with finished product                                                                       | 26/11/2009 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                    |
| R/0054  | Renewal of the marketing authorisation.                                                                                                                           | 25/06/2009 | 21/09/2009 | SmPC, Annex II, Labelling and PL | Based on quality, efficacy and safety documentation submitted, the CHMP is of the opinion that the renewal can be granted with unlimited validity and agree to renew the Marketing Authorisation of Ferriprox. The MAH will continue to submit 6 monthly PSURs, unless otherwise specified by the CHMP. The Product information has been updated to implement QRD changes as part of this renewal. |
| N/0057  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                  | 25/06/2009 | n/a        | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                    |
| II/0053 | To add an alternative child-resistant (CR) cap for Ferriprox 100 mg/ml oral solution and consequently a new supplier for the alternative closure. Quality changes | 19/03/2009 | 25/03/2009 |                                  |                                                                                                                                                                                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

| IA/0056   | IA_07_a_Replacement/add. of manufacturing site: Secondary packaging site                                                                                                                           | 17/03/2009   | n/a        |                        |                                                                                                                                                                                                                            |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0055   | IA_23_b_Change in source of excip./reagent to veg./synthetic material - other cases                                                                                                                | 11/03/2009   | n/a        |                        |                                                                                                                                                                                                                            |
| N/0051    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                   | 19/02/2009   | n/a        | PL                     |                                                                                                                                                                                                                            |
| IA/0050   | IA_08_b_02_Change in BR/QC testing - repl./add. manuf. responsible for BR - incl. BC/testing                                                                                                       | 22/10/2008   | n/a        | Annex II and PL        |                                                                                                                                                                                                                            |
| IA/0049   | IA_29_b_Change in qual./quant. composition of immediate packaging - all other pharm. forms                                                                                                         | 27/08/2008   | n/a        |                        |                                                                                                                                                                                                                            |
| IB/0047   | IB_13_b_Change in test proc. for active substance - other changes (replacement/addition)                                                                                                           | 08/07/2008   | n/a        |                        |                                                                                                                                                                                                                            |
| IB/0046   | IB_14_a_Change in manuf. of active substance without Ph. Eur. certificate - change in manuf. site                                                                                                  | 04/07/2008   | n/a        |                        |                                                                                                                                                                                                                            |
| IA/0048   | IA_13_a_Change in test proc. for active substance - minor change                                                                                                                                   | 04/07/2008   | n/a        |                        |                                                                                                                                                                                                                            |
| IB/0045   | IB_31_b_Change to in-process tests/limits during manufacture - addition of new tests/limits                                                                                                        | 30/04/2008   | n/a        |                        |                                                                                                                                                                                                                            |
| II/0043   | The MAH applied for an update of Section 4.8 of the SPC to add headache and fatigue following the assessment of the 15th PSUR. Furthermore, the incidences of agranulocytosis and neutropenia have | 19/03/2008   | 23/04/2008 | SmPC, Labelling and PL | Following the review of the 15th Periodic Safety Update Report , the CHMP requested that the product information should be amended to include headache (common) and fatigue (common) to Section 4.8 of the SPC. The PL has |

<div style=\"page-break-after: always\"></div>

|         | been amended and the entire Section 4.8 has been amended in line with the SPC guideline and QRD templates. Section 4 of the package leaflet has been amended accordingly. In addition, the MAH applied to relocate the patient/carer reminder card from Annex IIIA (labelling) to Annex IIIB (PL). Cross-reference statements have been included to the beginning and to Section 2 of the PL. Finally, the MAH took the opportunity to update the information in Braille in the Labelling and the list of local representatives for Belgium and Luxembourg in the Package Leaflet. Update of Summary of Product Characteristics, Labelling and Package Leaflet   |            |            |                        | been amended accordingly. Furthermore, the incidence of agranulocytosis and neutropenia has been corrected in Section 4.8 of the SPC. In addition the patient/carer reminder card has been relocated from Annex IIIA (Labelling) to Annex IIIB (PL). Cross-reference statements have been included to the PL. Finally, the information in Braille in the labelling and the list of local representatives for Belgium and Luxembourg in the Package Leaflet have been updated.   |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0044 | IB_33_Minor change in the manufacture of the finished product                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 27/11/2007 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| X/0036  | Ferriprox, 100 mg/ml, oral solution has been authorised. Annex I_2.(d) Change or addition of a new pharmaceutical form                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 20/09/2007 | 19/11/2007 | SmPC, Labelling and PL | Ferriprox, 100 mg/ml, oral solution has been authorised.                                                                                                                                                                                                                                                                                                                                                                                                                        |
| T/0042  | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 08/06/2007 | 29/06/2007 | SmPC, Labelling and PL | Transfer from Apotex Europe Ltd. to Apotex Europe B.V.                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IA/0041 | IA_22_a_Submission of TSE Ph. Eur. certificate for exc. - Approved/new manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 07/02/2007 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| N/0040   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                             | 02/02/2007   | n/a        | PL                               |                                                                                                                                                                                                                                                                                        |
|----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0039  | Update of sections 4.2, 4.4, 4.8 and 4.9 following the assessment of the 13th PSUR, and further updates to sections 4.4 and 4.5. Update of Summary of Product Characteristics, Labelling and Package Leaflet | 14/12/2006   | 26/01/2007 | SmPC, Annex II, Labelling and PL | Update of the information pertaining to chronic overdose and the risk of neurological disorders and strengthening the wording on neutropenia and agranulocytosis and the monitoring of patient's neutrophil counts. In addition, the latest QRD template (V 7.2) is being implemented. |
| IA/0038  | IA_22_a_Submission of TSE Ph. Eur. certificate for exc. - Approved/new manufacturer                                                                                                                          | 09/08/2006   | n/a        |                                  |                                                                                                                                                                                                                                                                                        |
| N/0037   | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                             | 17/03/2006   | n/a        | PL                               |                                                                                                                                                                                                                                                                                        |
| IA/0035  | IA_38_a_Change in test procedure of finished product - minor change to approved test procedure                                                                                                               | 10/03/2006   | n/a        |                                  |                                                                                                                                                                                                                                                                                        |
| II/0034  | Update of Summary of Product Characteristics (4.9) and Package Leaflet (3). Update of Summary of Product Characteristics and Package Leaflet                                                                 | 14/12/2005   | 30/01/2006 | SmPC and PL                      | Inclusion of case of chronic overdose reported with deferiprone.                                                                                                                                                                                                                       |
| IA/0033  | IA_22_a_Submission of TSE Ph. Eur. certificate for exc. - Approved/new manufacturer                                                                                                                          | 27/07/2005   | n/a        |                                  |                                                                                                                                                                                                                                                                                        |
| II/0032  | Quality changes                                                                                                                                                                                              | 16/03/2005   | 23/03/2005 |                                  |                                                                                                                                                                                                                                                                                        |

<div style=\"page-break-after: always\"></div>

|         | in shelf-life of finished product as packaged for sale                                                                                                   | 23/12/2004   | n/a        | SmPC        | IB/0031 IB_42_a_01_Change -   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-------------------------------|
| IB/0030 | IB_13_b_Change in test proc. for active substance - other changes (replacement/addition)                                                                 | 03/12/2004   | n/a        |             |                               |
| IA/0029 | IA_13_a_Change in test proc. for active substance - minor change                                                                                         | 08/11/2004   | n/a        |             |                               |
| IA/0028 | IA_05_Change in the name and/or address of a manufacturer of the finished product                                                                        | 20/10/2004   | n/a        |             |                               |
| IA/0027 | IA_04_Change in name and/or address of a manuf. of the active substance (no Ph. Eur. cert. avail.)                                                       | 20/10/2004   | n/a        |             |                               |
| R/0026  | Renewal of the marketing authorisation.                                                                                                                  | 23/06/2004   | 02/09/2004 |             |                               |
| II/0023 | changes to the specification of the active substance and finished product Change(s) to the test method(s) and/or specifications for the active substance | 03/06/2004   | 09/06/2004 |             |                               |
| II/0017 | Extension of Indication Update of Summary of Product Characteristics and Package Leaflet                                                                 | 24/03/2004   | 07/05/2004 | SmPC and PL |                               |
| IA/0025 | IA_08_a_Change in BR/QC testing - repl./add. of batch control/testing site                                                                               | 30/03/2004   | n/a        |             |                               |
| IA/0024 | IA_07_a_Replacement/add. of manufacturing site:                                                                                                          | 30/03/2004   | n/a        |             |                               |

<div style=\"page-break-after: always\"></div>

|         | Secondary packaging site                                                                                                                                                                              |            |            |                        |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| IA/0021 | IA_12_a_Change in spec. of active subst./agent used in manuf. of active subst. - tightening of spec. IA_37_a_Change in the specification of the finished product - tightening of specification limits | 10/03/2004 | n/a        |                        |
| IB/0018 | IB_30_b_Change in supplier of packaging components - replacement/addition                                                                                                                             | 03/02/2004 | n/a        |                        |
| IA/0020 | IA_22_a_Submission of TSE Ph. Eur. certificate for exc. - Approved/new manufacturer                                                                                                                   | 28/01/2004 | n/a        |                        |
| IA/0019 | IA_29_b_Change in qual./quant. composition of immediate packaging - all other pharm. forms                                                                                                            | 28/01/2004 | n/a        |                        |
| II/0016 | Update of Summary of Product Characteristics and Package Leaflet                                                                                                                                      | 26/06/2003 | 03/10/2003 | SmPC and PL            |
| I/0014  | 31_Change in container shape                                                                                                                                                                          | 16/04/2003 | 28/04/2003 |                        |
| I/0013  | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                                                                                        | 16/04/2003 | 28/04/2003 |                        |
| N/0015  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                      | 11/04/2003 | 12/05/2003 | PL                     |
| I/0012  | 03_Change in the name and/or address of the marketing authorisation holder                                                                                                                            | 04/03/2003 | 10/04/2003 | SmPC, Labelling and PL |

<div style=\"page-break-after: always\"></div>

|         | 01_Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                            | 25/03/2003   | 31/03/2003   |                        | I/0011         |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|----------------|
| I/0010  | 13_Batch size of active substance                                                                                                         | 21/06/2002   | 28/06/2002   |                        |                |
| S/0009  | Annual                                                                                                                                    | 13/12/2001   | 12/04/2002   | Annex II               | re-assessment. |
| S/0005  | Annual re-assessment.                                                                                                                     | 16/11/2000   | 05/02/2002   |                        |                |
| II/0008 | Update of or change(s) to the pharmaceutical documentation Change(s) to the test method(s) and/or specifications for the active substance | 25/04/2001   | 02/05/2001   |                        |                |
| N/0006  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                          | 24/01/2001   | 06/03/2001   | Labelling and PL       |                |
| I/0004  | 20a_Extension of shelf-life or retest period of the active substance                                                                      | 16/11/2000   | n/a          |                        |                |
| I/0003  | 11_Change in or addition of manufacturer(s) of active substance                                                                           | 15/11/2000   | n/a          |                        |                |
| N/0002  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                          | 05/10/2000   | 01/12/2000   | PL                     |                |
| I/0001  | 03_Change in the name and/or address of the marketing authorisation holder                                                                | 09/12/1999   | 22/02/2000   | SmPC, Labelling and PL |                |